Who Paid My Doc
Christine Burt Solorzano
Pediatric Endocrinology Charlottesville, VA Medical Doctor
NPI 1306000997 CMS profile 684755
1204 W Main St, Charlottesville, VA 22903
General payments
$180
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$284,435
Through program year 2025, Christine Burt Solorzano of Charlottesville, VA is reported in the CMS Open Payments database as having received $180 across 2 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $284,435 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 27th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $71 | 1 | |
| 2024 | General | $109 | 1 |
Beside peers
- Christine Burt Solorzano
- Pediatric Endocrinology median
- Middle half of Pediatric Endocrinology
- National median
In program year 2025, general payments to Christine Burt Solorzano were reported at $71. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.
Show as a table
| Year | Christine Burt Solorzano | Pediatric Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $196 | $68–$845 | $163 |
| 2020 | $0 | $124 | $37–$722 | $114 |
| 2021 | $0 | $134 | $35–$691 | $132 |
| 2022 | $0 | $177 | $47–$726 | $149 |
| 2023 | $0 | $236 | $75–$887 | $160 |
| 2024 | $109 | $259 | $91–$979 | $164 |
| 2025 | $71 | $293 | $106–$1,640 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
35
Drug cost
$9,169
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | Brand | 12 | $6,585 | |
| Novolog Flexpen Insulin Aspart | Brand | 11 | $1,465 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 12 | $1,119 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Endocrinology in Virginia
Kent Reifschneider
Pediatric Endocrinology · Norfolk, VA
Bryce Nelson
Pediatric Endocrinology · Richmond, VA
David Repaske
Pediatric Endocrinology · Charlottesville, VA
Eric Gyuricsko
Pediatric Endocrinology · Norfolk, VA
Melissa Schoelwer
Pediatric Endocrinology · Charlottesville, VA
Maria Farida Pingul
Pediatric Endocrinology · Fairfax, VA
Related records
Pediatric Endocrinology in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.